At a glance
- Originator GlaxoSmithKline
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action GABA uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 30 Jan 1997 No-Development-Reported for Epilepsy in Sweden (unspecified route)
- 10 Nov 1994 No-Development-Reported for Epilepsy in United Kingdom (unspecified route)
- 10 Nov 1994 Preclinical development for Epilepsy in Sweden (unspecified route)